funder-graph

FundersCAInternational Myeloma Foundation › 2023

Grants paid by International Myeloma Foundation, tax year 2023

EIN 95-4296919 · Studio City, CA · Form 990, Schedule I · NTEE Z99Z

In tax year 2023, International Myeloma Foundation (EIN 95-4296919) reported 4 grants paid totaling $120,000. Dataset version 2026.09.0, built 2026-09-03.

20182019202020212022202320242025

Every grant, 2023

Grants reported by International Myeloma Foundation for tax year 2023
Tax yearRecipientMatchAmountTypePurposeSource filing
2023Case Western Reserve University Cleveland, OHA$53,333paidNOVEL ADJUVANTS TO PROTEASOME INHIBITORS FOR MYELOMA THERAPY202442079349300024
2023Dana Farber Cancer Institute Boston, MAA$33,333paidDEFINING CELL STATES UNDERLYING TREATMENT RESISTANCE IN MYELOMA BY INTEGRATING MULTIOMIC SEQUENCING DATA202442079349300024
2023Trustees of Boston University Boston, MAA$16,667paidDEFINING A MOLECULAR SIGNATURE OF CARDIOTOXICITY IN SYSTEMIC IMMUNOGLOBIN LIGHT CHAIN AMYLOIDOSIS202442079349300024
2023University of San Diego San Diego, CAA$16,667paidTUNING THE INNATE IMMUNE MULTIPLE MYELOMA MICROENVIRONMENT BY MODULATING IRF4202442079349300024

Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.

Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.

Derived from IRS Form 990 e-file XML. Dataset version 2026.09.0, built 2026-09-03. All years for this funder.

The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.

This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.